Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.
Suppression of endogenous glucose production (EGP) is one of insulin's primary metabolic effects and failure of this action is a major contributor to fasting hyperglycemia of type 2 diabetes mellitus. Classically, insulin was thought to suppress the liver directly, via hyperinsulinemia in the portal...
Gardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Clinical Investigation
1997
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508525/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9399959/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119867 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
